Corcept Therapeutics | CORT - Pre Tax Profit

Stock Price
40.82
Daily Change
2.46 6.41%
Monthly
10.32%
Yearly
-39.98%
Q1 Forecast
38.64

Corcept Therapeutics reported $15.24M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 44.6M 4.38M Sep/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Ardelyx USD -867K 18.21M Sep/2025
Aurora Cannabis CAD 46.98M 66.36M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Canopy Growth CAD -1.42M 39.82M Sep/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Merck USD 6.74B 22M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Novartis USD 5.17B 637M Sep/2025
Pacira USD -1.93M 10.63M Jun/2025
Pfizer USD 3.33B 290M Sep/2025
Supernus Pharmaceuticals USD -57.95M 74.62M Sep/2025
TG Therapeutics USD 25.91M 5.01M Sep/2025